Angiogenic factors: potential to change clinical practice in pre‐eclampsia?

por Cerdeira, AS, Agrawal, S, Staff, AC, Redman, CW, Vatish, M
Publicado 2017

sFlt‐1/PlGF ratio test for pre‐eclampsia: an economic assessment for the UK

por Vatish, M., Strunz‐McKendry, T., Hund, M., Allegranza, D., Wolf, C., Smare, C.
Publicado 2016

Implementation of the sFlt-1/PlGF ratio for prediction and diagnosis of pre-eclampsia in singleton pregnancy: implications for clinical practice

por Stepan, H, Herraiz, I, Schlembach, D, Verlohren, S, Brennecke, S, Chantraine, F, Klein, E, Lapaire, O, Llurba, E, Ramoni, A, Vatish, M, Wertaschnigg, D, Galindo, A
Publicado 2015

Soluble fms‐like tyrosine kinase‐1 to placental growth factor ratio: ruling out pre‐eclampsia for up to 4 weeks and value of retesting

por Zeisler, H., Llurba, E., Chantraine, F. J., Vatish, M., Staff, A. C., Sennström, M., Olovsson, M., Brennecke, S. P., Stepan, H., Allegranza, D., Schoedl, M., Grill, S., Hund, M., Verlohren, S.
Publicado 2019